Tenet Healthcare Corporation (NYSE:THC) has a beta value of 2.62 and has seen 1,312,056 shares traded in the last trading session. The company, currently valued at $6.63 Billion, closed the last trade at $62.3 per share which meant it gained $3.04 on the day or 5.13% during that session. The THC stock price is -1.33% off its 52-week high price of $63.13 and 77.38% above the 52-week low of $14.09. If we look at the company’s 10-day average daily trading volume, we find that it stood at 912.62 Million shares traded. The 3-month trading volume is 1.02 Million shares.
The consensus among analysts is that Tenet Healthcare Corporation (THC) is an Overweight stock at the moment, with a recommendation rating of 2.1. None of the analysts rate the stock as a Sell, while 1 rate it as Overweight. 6 out of 16 have rated it as a Hold, with 9 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $1.08.
Tenet Healthcare Corporation (NYSE:THC) trade information
Sporting 5.13% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Monday, May 03 when the THC stock price touched $63.13- or saw a rise of 1.32%. Year-to-date, Tenet Healthcare Corporation shares have moved 56.02%, while the 5-day performance has seen it change 11.49%. Over the past 30 days, the shares of Tenet Healthcare Corporation (NYSE:THC) have changed 21.7%. Short interest in the company has seen 3.52 Million shares shorted with days to cover at 3.45.
Wall Street analysts have a consensus price target for the stock at $66.29, which means that the shares’ value could jump 6.4% from current levels. The projected low price target is $48 while the price target rests at a high of $89. In that case, then, we find that the current price level is +42.86% off the targeted high while a plunge would see the stock lose -22.95% from current levels.
Tenet Healthcare Corporation (THC) estimates and forecasts
Figures show that Tenet Healthcare Corporation shares have underperformed across the wider relevant industry. The company’s shares have gained +147.12% over the past 6 months, with this year growth rate of 10.99%, compared to 12.5% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2021 fiscal year revenue. Growth estimates for the current quarter are -14.3% and 68.8% for the next quarter. Revenue growth from the last financial year stood is estimated to be +11.6%.
10 analysts offering their estimates for the company have set an average revenue estimate of $4.79 Billion for the current quarter. 10 have an estimated revenue figure of $4.9 Billion for the next quarter concluding in September 01, 2021. Year-ago sales stood $3.65 Billion and $4.4 Billion respectively for this quarter and the next, and analysts expect sales will grow by 31.2% for the current quarter and 11.2% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +35.8% over the past 5 years. Earnings growth for 2021 is a modest +259.8% while over the next 5 years, the company’s earnings are expected to increase by 3.98%.
Tenet Healthcare Corporation (NYSE:THC)’s Major holders
Insiders own 1.59% of the company shares, while shares held by institutions stand at 86.56% with a share float percentage of 87.96%. Investors are also buoyed by the number of investors in a company, with Tenet Healthcare Corporation having a total of 387 institutions that hold shares in the company. The top two institutional holders are Glenview Capital Management, LLC with over 18.26 Million shares worth more than $729.07 Million. As of December 30, 2020, Glenview Capital Management, LLC held 17.15% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 12.19 Million shares as of December 30, 2020. The firm’s total holdings are worth over $486.79 Million and represent 11.45% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Core S&P Midcap ETF. As of December 30, 2020, the former fund manager holds about 2.8% shares in the company for having 2978270 shares of worth $118.92 Million while later fund manager owns 2.86 Million shares of worth $148.94 Million as of March 30, 2021, which makes it owner of about 2.69% of company’s outstanding stock.